Chan A, Cohan S, Stark J, et al. Treatment with delayed-release dimethyl fumarate is associated with fewer relapses versus glatiramer acetate in patients with relapsing remitting multiple sclerosis: real-world comparative effectiveness analyses from the EFFECT study. ECTRIMS 2017, P1160.
Atogepant (Aquipta) vergoed voor preventieve behandeling van therapieresistente chronische migraine
dec 2024 | Hoofdpijn